Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Satsuma Pharmaceuticals

NASDAQ STSA
- - -%
Today share price
USA
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 16 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

36.47M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
20.18M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.19
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
33.15M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-

Upcoming events Satsuma Pharmaceuticals

All events
No upcoming events scheduled
Overview Financials Key Metrics Dividends Industry overview Events

Stock chart Satsuma Pharmaceuticals

Stock analysis Satsuma Pharmaceuticals

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-0.57 35.52
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
-0.17 13.63
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-0.31 17.42
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.25 0.37
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-168.58 8.90

Price change Satsuma Pharmaceuticals per year

3.50$ 7.48$
Min Max

Summary analysis Satsuma Pharmaceuticals

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Satsuma Pharmaceuticals

Revenue and net income Satsuma Pharmaceuticals

All parameters

Stock news Satsuma Pharmaceuticals

All news
17 April 2023 в 13:30

Satsuma Pharmaceuticals Shares Soar on Shin Nippon Biomedical Deal >STSA

17 April 2023 в 13:30

Satsuma Pharmaceuticals Shares Soar on Shin Nippon Biomedical Deal >STSA

14 November 2022 в 15:30

Satsuma Pharmaceuticals Drops After Migraine Drug Falls Short in Trial

14 November 2022 в 15:30

Satsuma Pharmaceuticals Drops After Migraine Drug Falls Short in Trial

About company Satsuma Pharmaceuticals

Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. Its lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in ASCEND Phase III clinical trials and can be self-administered with proprietary pre-filled, single-use, and nasal delivery device. The company was incorporated in 2016 and is headquartered in South San Francisco, California.
Address:
400 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Company name: Satsuma Pharmaceuticals
Issuer ticker: STSA
ISIN: US80405P1075
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2019-09-13
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.satsumarx.com

On which stock exchange are Satsuma Pharmaceuticals (STSA) stocks traded?

Satsuma Pharmaceuticals (STSA) stocks are traded on NASDAQ.

What is the ticker of Satsuma Pharmaceuticals stocks (STSA)?

The stock ticker of Satsuma Pharmaceuticals’s stocks or in other words, the code is STSA. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Satsuma Pharmaceuticals (STSA) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Satsuma Pharmaceuticals (STSA) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Satsuma Pharmaceuticals (STSA) stocks traded?

Satsuma Pharmaceuticals (STSA) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Satsuma Pharmaceuticals (STSA) stocks today?

The current price of Satsuma Pharmaceuticals stocks on 04.05.2024 is dollars. per share.

What is the dynamics of Satsuma Pharmaceuticals (STSA) stocks from the beginning of the year?

Satsuma Pharmaceuticals (STSA) quotes have increased by 0% from the beginning of the year up to dollars. per 1 stocks.

How much did Satsuma Pharmaceuticals (STSA) stocks increase in мае 2024?

This month Satsuma Pharmaceuticals (STSA) quotes have increased by 0% to dollars. per share.

How much are Satsuma Pharmaceuticals (STSA) stocks worth?

Today, on October, 04.05.2024 Satsuma Pharmaceuticals’s (STSA) stocks cost dollars..

What is the market capitalization of Satsuma Pharmaceuticals (STSA)?

Capitalization is the market value of Satsuma Pharmaceuticals (STSA) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 04.05.2024, the market capitalization of Satsuma Pharmaceuticals (STSA) is estimated at about 36467748 dollars.